PCV51 Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Adult Patients With Non-Valvular Atrial Fibrillation with One or More Risk Factors – A UK Perspective

Saved in:

Bibliographic Details
Published in	Value in health Vol. 15; no. 7; p. A371
Main Authors	Asukai, Y, Duran, A, Lloyd, A, McLeod, E.J, Evers, T, Broughton, J
Format	Journal Article
Language	English
Published	Elsevier Inc 01.11.2012
Subjects	Internal Medicine
Online Access	Get full text

Loading…

More Information
ISSN:	1098-3015 1524-4733
DOI:	10.1016/j.jval.2012.08.994